Aridol, an innovative lung function test by Pharmaxis, failed to win approval from US FDA which said that it needs more clinical data for approval.

Diabetes is diagnosed once A1C level rose to 6.5 percent or higher

Allovectin-7, an experimental vaccine to treat advanced melanoma, has shown encouraging results in late phase human studies, Vical inc, the developer of Allovectin-7 reported.

CGEN-671, a new drug target for multiple epithelial tumors, has been identified by Compugen.

A vaccine against human enterovirus 71 (EV 71), which causes hand, foot, and mouth disease (HFMD), by Sinovac Biotech, will soon undergo human clinical studies in China.

Rimonabant, the controversial weight-loss drug in Acomplia implicated in several serious side-effects and psychiatric problems including suicide ideation, has been finally banned in India.

Zolpimist, an oral spray containing the sleep-inducing drug zolpidem to treat insomnia has received US patent, NovaDel Pharma Inc said in  an official release.

Lorcaserin, an experimental therapy by Arena Pharmaceuticals, for people who want to lose weight and maintain the weight loss without much side-effects may be well on its way to markets .

Lupin is already being sued  in the Northern District Court of California on Glumetza generic

MDY-1001, an oral therapy to protect the digestive tract from the harmful effects of radiation induced damage during cancer treatment is being developed by Midway Pharmaceuticals.